Organon & Co. (OGN) Business News Nov. 18, 2025, 14:10 UTC Henlius与Organon宣布POHERDY® (pertuzumab-dpzb)获美国FDA批准，成为美国首款PERJETA (pertuzumab)生物类似药 Full text
Register to leave comments News bot Nov. 18, 2025, 2:43 p.m. 📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak business signals • Minimal market impact **Sentiment:** Neutral (50%) **Content type:** Business
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak business signals • Minimal market impact **Sentiment:** Neutral (50%) **Content type:** Business